Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
HKD 5.78
(0.0%)
HKD 5.78
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.78 Billion CNY | 19.12% |
| 2022 | 1.49 Billion CNY | 17.2% |
| 2021 | 1.27 Billion CNY | 0.23% |
| 2020 | 1.27 Billion CNY | -6.82% |
| 2019 | 1.36 Billion CNY | 19.46% |
| 2018 | 1.14 Billion CNY | 21.2% |
| 2017 | 942.61 Million CNY | 19.24% |
| 2016 | 790.54 Million CNY | 15.07% |
| 2015 | 686.98 Million CNY | 13.77% |
| 2014 | 603.83 Million CNY | 29.86% |
| 2013 | 464.97 Million CNY | -1.28% |
| 2012 | 471.01 Million CNY | 21.12% |
| 2011 | 388.86 Million CNY | 25.72% |
| 2010 | 309.3 Million CNY | 4.48% |
| 2009 | 296.04 Million CNY | 30.67% |
| 2008 | 226.56 Million CNY | -0.5% |
| 2007 | 227.7 Million CNY | -12.22% |
| 2006 | 259.4 Million CNY | -5.67% |
| 2005 | 274.98 Million CNY | 1.43% |
| 2004 | 271.09 Million CNY | 12.29% |
| 2003 | 241.43 Million CNY | 4.36% |
| 2002 | 231.34 Million CNY | -1.94% |
| 2001 | 235.92 Million CNY | 9.48% |
| 2000 | 215.5 Million CNY | 13.82% |
| 1999 | 189.34 Million CNY | 9.83% |
| 1998 | 172.39 Million CNY | 84.33% |
| 1997 | 93.52 Million CNY | 20.48% |
| 1996 | 77.62 Million CNY | 17.97% |
| 1995 | 65.8 Million CNY | -5.14% |
| 1994 | 69.36 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 297.37 Million CNY | -4.67% |
| 2024 Q1 | 507.55 Million CNY | 35.32% |
| 2024 Q2 | 322.05 Million CNY | -36.55% |
| 2023 Q4 | 375.07 Million CNY | -3.02% |
| 2023 Q2 | 390.08 Million CNY | -37.84% |
| 2023 FY | 1.77 Billion CNY | 19.12% |
| 2023 Q3 | 386.76 Million CNY | -0.85% |
| 2023 Q1 | 627.58 Million CNY | 40.19% |
| 2022 Q1 | 355.37 Million CNY | 16.44% |
| 2022 Q4 | 447.65 Million CNY | 22.93% |
| 2022 Q3 | 364.15 Million CNY | 11.46% |
| 2022 FY | 1.49 Billion CNY | 17.2% |
| 2022 Q2 | 326.72 Million CNY | -8.06% |
| 2021 Q3 | 251.77 Million CNY | -26.68% |
| 2021 Q1 | 374.3 Million CNY | 16.36% |
| 2021 Q2 | 343.4 Million CNY | -8.26% |
| 2021 Q4 | 305.19 Million CNY | 21.22% |
| 2021 FY | 1.27 Billion CNY | 0.23% |
| 2020 Q4 | 321.68 Million CNY | 9.33% |
| 2020 Q1 | 355.34 Million CNY | 5.97% |
| 2020 FY | 1.27 Billion CNY | -6.82% |
| 2020 Q3 | 294.22 Million CNY | -2.08% |
| 2020 Q2 | 300.46 Million CNY | -15.45% |
| 2019 Q2 | 337.72 Million CNY | -15.47% |
| 2019 FY | 1.36 Billion CNY | 19.46% |
| 2019 Q1 | 399.53 Million CNY | 29.28% |
| 2019 Q3 | 292.16 Million CNY | -13.49% |
| 2019 Q4 | 335.32 Million CNY | 14.77% |
| 2018 Q2 | 259.94 Million CNY | -13.43% |
| 2018 Q3 | 273.2 Million CNY | 5.1% |
| 2018 FY | 1.14 Billion CNY | 21.2% |
| 2018 Q1 | 300.27 Million CNY | 29.7% |
| 2018 Q4 | 309.05 Million CNY | 13.12% |
| 2017 Q3 | 209.22 Million CNY | -7.73% |
| 2017 Q1 | 275.11 Million CNY | 18.34% |
| 2017 Q2 | 226.74 Million CNY | -17.58% |
| 2017 FY | 942.61 Million CNY | 19.24% |
| 2017 Q4 | 231.52 Million CNY | 10.65% |
| 2016 FY | 790.54 Million CNY | 15.07% |
| 2016 Q3 | 198.56 Million CNY | 17.95% |
| 2016 Q2 | 168.34 Million CNY | -11.94% |
| 2016 Q1 | 191.17 Million CNY | 3.53% |
| 2016 Q4 | 232.47 Million CNY | 17.08% |
| 2015 FY | 686.98 Million CNY | 13.77% |
| 2015 Q1 | 190.96 Million CNY | -11.5% |
| 2015 Q4 | 184.65 Million CNY | 19.57% |
| 2015 Q3 | 154.43 Million CNY | -1.57% |
| 2015 Q2 | 156.88 Million CNY | -17.84% |
| 2014 Q3 | 122.94 Million CNY | -10.97% |
| 2014 Q4 | 215.76 Million CNY | 75.49% |
| 2014 FY | 603.83 Million CNY | 29.86% |
| 2014 Q1 | 127.01 Million CNY | -4.0% |
| 2014 Q2 | 138.09 Million CNY | 8.73% |
| 2013 Q1 | 108.09 Million CNY | -12.88% |
| 2013 Q3 | 110.89 Million CNY | -2.46% |
| 2013 FY | 464.97 Million CNY | -1.28% |
| 2013 Q4 | 132.3 Million CNY | 19.31% |
| 2013 Q2 | 113.68 Million CNY | 5.18% |
| 2012 Q3 | 121.95 Million CNY | -3.34% |
| 2012 Q2 | 126.17 Million CNY | 27.7% |
| 2012 FY | 471.01 Million CNY | 21.12% |
| 2012 Q1 | 98.8 Million CNY | -16.4% |
| 2012 Q4 | 124.07 Million CNY | 1.73% |
| 2011 Q4 | 118.19 Million CNY | 24.22% |
| 2011 Q1 | 88.28 Million CNY | 31.58% |
| 2011 Q2 | 87.23 Million CNY | -1.18% |
| 2011 Q3 | 95.15 Million CNY | 9.07% |
| 2011 FY | 388.86 Million CNY | 25.72% |
| 2010 Q3 | 68.06 Million CNY | -17.52% |
| 2010 FY | 309.3 Million CNY | 4.48% |
| 2010 Q1 | 91.63 Million CNY | 43.4% |
| 2010 Q2 | 82.51 Million CNY | -9.95% |
| 2010 Q4 | 67.09 Million CNY | -1.42% |
| 2009 Q3 | 72.18 Million CNY | -2.77% |
| 2009 Q2 | 74.23 Million CNY | -13.41% |
| 2009 FY | 296.04 Million CNY | 30.67% |
| 2009 Q1 | 85.72 Million CNY | 36.4% |
| 2009 Q4 | 63.9 Million CNY | -11.47% |
| 2008 FY | 226.56 Million CNY | -0.5% |
| 2008 Q4 | 62.85 Million CNY | 25.78% |
| 2008 Q3 | 49.96 Million CNY | 9.2% |
| 2008 Q2 | 45.75 Million CNY | -32.69% |
| 2008 Q1 | 67.98 Million CNY | 17.88% |
| 2007 Q2 | 57.83 Million CNY | -11.47% |
| 2007 Q1 | 65.32 Million CNY | -5.6% |
| 2007 FY | 227.7 Million CNY | -12.22% |
| 2007 Q4 | 57.67 Million CNY | 23.01% |
| 2007 Q3 | 46.88 Million CNY | -18.94% |
| 2006 Q4 | 69.2 Million CNY | 26.63% |
| 2006 Q3 | 54.64 Million CNY | -9.66% |
| 2006 Q2 | 60.49 Million CNY | -19.42% |
| 2006 FY | 259.4 Million CNY | -5.67% |
| 2006 Q1 | 75.06 Million CNY | -9.71% |
| 2005 Q2 | 66.17 Million CNY | 0.74% |
| 2005 Q4 | 83.13 Million CNY | 38.59% |
| 2005 Q3 | 59.98 Million CNY | -9.34% |
| 2005 FY | 274.98 Million CNY | 1.43% |
| 2005 Q1 | 65.68 Million CNY | -40.85% |
| 2004 Q3 | 46.72 Million CNY | -20.62% |
| 2004 Q1 | 54.45 Million CNY | -33.97% |
| 2004 FY | 271.09 Million CNY | 12.29% |
| 2004 Q2 | 58.86 Million CNY | 8.1% |
| 2004 Q4 | 111.04 Million CNY | 137.65% |
| 2003 FY | 241.43 Million CNY | 4.36% |
| 2003 Q3 | 48.45 Million CNY | -6.74% |
| 2003 Q2 | 51.95 Million CNY | -11.28% |
| 2003 Q1 | 58.56 Million CNY | -18.0% |
| 2003 Q4 | 82.46 Million CNY | 70.2% |
| 2002 Q2 | 55.7 Million CNY | 7.21% |
| 2002 Q1 | 51.95 Million CNY | 0.0% |
| 2002 Q3 | 52.27 Million CNY | -6.15% |
| 2002 Q4 | 71.41 Million CNY | 36.61% |
| 2002 FY | 231.34 Million CNY | -1.94% |
| 2001 FY | 235.92 Million CNY | 9.48% |
| 2000 FY | 215.5 Million CNY | 13.82% |
| 1999 FY | 189.34 Million CNY | 9.83% |
| 1998 FY | 172.39 Million CNY | 84.33% |
| 1997 FY | 93.52 Million CNY | 20.48% |
| 1996 FY | 77.62 Million CNY | 17.97% |
| 1995 FY | 65.8 Million CNY | -5.14% |
| 1994 FY | 69.36 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 24.42 Million HKD | -7215.683% |
| Grand Pharmaceutical Group Limited | 3.86 Billion HKD | 53.718% |
| Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | -4929.365% |
| Wai Yuen Tong Medicine Holdings Limited | 353.93 Million HKD | -404.836% |
| Qianhai Health Holdings Limited | 17.1 Million HKD | -10347.799% |
| Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | -202.336% |
| Essex Bio-Technology Limited | 1.22 Billion HKD | -45.389% |
| Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | -254.898% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -724.812% |
| SSY Group Limited | 1.98 Billion HKD | 9.792% |
| JBM (Healthcare) Limited | 163.87 Million HKD | -990.326% |
| Jacobson Pharma Corporation Limited | 287.34 Million HKD | -521.816% |
| China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 93.913% |